US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Fortress Biotech Inc (FBIO)
Fortress Biotech Inc (FBIO) ニュース

FBIO

Fortress Biotech (FBIO)

Fortress Biotech Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FBIO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/03/12	21 : 30	GlobeNewswire Inc.	Journey Medical Corporation to Participate in the 37th Annual ROTH Conference	NASDAQ:FBIO	Fortress Biotech Inc
2025/03/11	07 : 41	PR Newswire (US)	CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma	NASDAQ:FBIO	Fortress Biotech Inc
2025/03/10	11 : 06	PR Newswire (US)	Sun Pharma to Acquire Checkpoint Therapeutics	NASDAQ:FBIO	Fortress Biotech Inc
2025/03/06	06 : 15	GlobeNewswire Inc.	Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement	NASDAQ:FBIO	Fortress Biotech Inc
2025/03/06	06 : 01	GlobeNewswire Inc.	Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea	NASDAQ:FBIO	Fortress Biotech Inc
2025/03/05	06 : 01	GlobeNewswire Inc.	Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida	NASDAQ:FBIO	Fortress Biotech Inc
2025/02/28	06 : 05	GlobeNewswire Inc.	Mustang Bio Announces Sale of Fixed Assets and Exit of Facility	NASDAQ:FBIO	Fortress Biotech Inc
2025/02/12	06 : 10	GlobeNewswire Inc.	Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement	NASDAQ:FBIO	Fortress Biotech Inc
2025/02/10	22 : 00	GlobeNewswire Inc.	Mustang Bio Announces Closing of $8 Million Public Offering	NASDAQ:FBIO	Fortress Biotech Inc
2025/02/06	21 : 00	GlobeNewswire Inc.	Mustang Bio Announces Pricing of $8 Million Public Offering	NASDAQ:FBIO	Fortress Biotech Inc
2025/01/27	22 : 30	GlobeNewswire Inc.	Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT	NASDAQ:FBIO	Fortress Biotech Inc
2025/01/23	22 : 30	GlobeNewswire Inc.	Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea	NASDAQ:FBIO	Fortress Biotech Inc
2025/01/14	22 : 00	GlobeNewswire Inc.	Mustang Bio Announces Reverse Stock Split	NASDAQ:FBIO	Fortress Biotech Inc
2025/01/06	22 : 00	GlobeNewswire Inc.	Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease	NASDAQ:FBIO	Fortress Biotech Inc
2025/01/06	22 : 00	PR Newswire (US)	Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) Product Candidate for Treatment of Menkes Disease	NASDAQ:FBIO	Fortress Biotech Inc
2024/11/15	06 : 10	GlobeNewswire Inc.	Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc
2024/11/15	06 : 05	GlobeNewswire Inc.	Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc
2024/11/13	06 : 01	GlobeNewswire Inc.	Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc
2024/11/12	22 : 30	GlobeNewswire Inc.	Mustang Bio Receives Positive Listing Determination from Nasdaq	NASDAQ:FBIO	Fortress Biotech Inc
2024/11/07	22 : 30	GlobeNewswire Inc.	Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma	NASDAQ:FBIO	Fortress Biotech Inc
2024/11/04	21 : 00	GlobeNewswire Inc.	Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea	NASDAQ:FBIO	Fortress Biotech Inc
2024/10/25	21 : 30	GlobeNewswire Inc.	Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference	NASDAQ:FBIO	Fortress Biotech Inc
2024/10/25	03 : 10	GlobeNewswire Inc.	Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds	NASDAQ:FBIO	Fortress Biotech Inc
2024/10/09	21 : 30	GlobeNewswire Inc.	Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit	NASDAQ:FBIO	Fortress Biotech Inc
2024/10/03	21 : 30	GlobeNewswire Inc.	Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference	NASDAQ:FBIO	Fortress Biotech Inc
2024/09/26	21 : 30	GlobeNewswire Inc.	Fortress Biotech to Participate in October 2024 Investor Conferences	NASDAQ:FBIO	Fortress Biotech Inc
2024/09/20	21 : 30	GlobeNewswire Inc.	Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements	NASDAQ:FBIO	Fortress Biotech Inc
2024/09/09	21 : 30	GlobeNewswire Inc.	Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference	NASDAQ:FBIO	Fortress Biotech Inc
2024/09/04	21 : 30	GlobeNewswire Inc.	Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:FBIO	Fortress Biotech Inc
2024/09/04	21 : 15	GlobeNewswire Inc.	Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:FBIO	Fortress Biotech Inc

Showing the most relevant articles for your search:NASDAQ:FBIO

1 2 3 4 5 6 7 8 9 10 次へ >>

Franklin Ultra Short Bon...

Rep Serbia 34 S

NYLI MacKay High Income ...

Spdr S&p 500 Etf

Templeton Russia

Sg Etc Brent Oil Future

Fidelity Minerals

Vontobel Financial Produ...

Eastern Goldfields

Power Corp Canada (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約